Compound Screening TRIZ Cases

Chemical surface patterns guide cell alignment on tissue scaffolds, resolving size limitations of mechanical methods.

Single cell transcriptional profiling identifies drug-responsive cells from biopsy samples within hours, avoiding toxic empiric therapies.

Dual Hedgehog and mTOR inhibition overcomes single-agent resistance in esophageal adenocarcinoma by blocking parallel survival signals.

Cyclophilin binding peptides activate dendritic cells, overcoming ineffective classical adjuvants by inducing type-I interferon secretion.

Serine protease assay detects glycosaminoglycans via chromogenic substrate cleavage, resolving low sensitivity in mucopolysaccharidosis diagnosis.

Circulating extracellular vesicles carrying IL-12Rβ2 replace invasive angiography, resolving the trade-off between diagnostic accuracy and patient trauma.

Biomarker composition predicts therapeutic agent susceptibility by measuring Ras activity levels in biological samples.

A cross-species cellular discovery platform identifies candidate therapeutic agents using yeast models and human induced pluripotent stem cell-derived neurons.

Pheophorbide a inhibits overactive FGFR3 using Amaranthus viridis extracts, addressing the lack of approved drugs for skeletal dysplasias.

Specialized diagnostic assays segment molecular characterization to improve measurement precision for FIG4 mutations without increasing system complexity.

Small molecules bind the TRAF6-Ubc13 interface to reduce NF-kB activation, treating rheumatoid arthritis and cancer.

A light-inducible intracellular protein aggregation system uses photoactivation to trigger controlled protein accumulation.

Indole derivatives correct protein folding defects in ABC transporters, restoring anion flow and fluid balance for effective disease treatment.

Segmented autoantibody panels resolve low sensitivity in early ovarian cancer detection while maintaining assay simplicity.

A porous polymer layer supports collagen and airway cells to enable neutrophil transmigration across the epithelial barrier.

Co-expressing SUMF1 in CHO cells overcomes secretion bottlenecks to yield active, highly phosphorylated lysosomal sulfatase enzymes.

High-throughput CD38 inhibitor assay uses coupling enzymes to generate luminescent and time-resolved fluorescent signals for compound library screening.

Segments complex biological preparations into defined peptide epitopes to resolve reproducibility and preparation complexity trade-offs.

SIP30 antagonists treat neuropathic pain by blocking pro-nociceptive signaling, avoiding systemic side effects of traditional analgesics.

Molecular modeling identifies inhibitors binding gp120 motifs to constrain flexibility, preventing CD4 receptor entry and overcoming drug resistance.

Targeting the Annexin A2 binding domain on PCSK9 blocks receptor degradation, resolving incomplete cholesterol lowering and side effects.

USP4 inhibitors exploit synthetic lethality to selectively destroy cancer cells with DNA damage response deficiencies.

Replacing plaque assays with NanoBiT technology, this method reduces detection time from days to minutes while maintaining accuracy without BSL-3 facilities.

An ALK inhibitor composition targets tau protein phosphorylation, resolving insufficient specificity in current degenerative neuronal disease therapies.

Responsive promoter-driven reporters enable high-throughput FGF2 detection, resolving the trade-off between assay versatility and measurement precision.

LIMP-2 peptides activate glucocerebrosidase for lysosomal delivery while binding viral proteins to prevent infections.

Fusing a conformation-selective binding domain to a GPCR stabilizes the receptor, enhancing drug screening sensitivity and selectivity.

Cap-domain mutations eliminate detergent aggregation, enabling atomic resolution structure determination for selective inhibitor design.

Targeting coil 2 residues resolves insufficient inhibition precision by blocking vimentin and hGIIA interaction.

Nanoparticle-mediated delivery of labeled ATP analogs to mutated kinases enables in vivo substrate identification without phosphatase interference.

Defined serum-free medium co-cultures human motoneurons and muscle cells to resolve culture variability from animal-derived components.

Focused light scattering detects biological particles by analyzing scattered light intensity across multiple angles to determine size and shape.

Formula I compounds boost frataxin expression to reduce mitochondrial iron accumulation and oxidative stress in neurodegenerative disease models.

A phospholipase C activator composition restores synaptic plasticity and contextual fear memory in Alzheimer's disease models.

Segmented polypeptides containing binding and spacer amino acids reduce crystal growth rates and alter morphology to suppress kidney stone incidence.

A hardening agent increases pancreatic tissue tension to prevent leakage during complex resection procedures.

Intron tagging resolves the contradiction between measurement precision and productivity by enabling scalable, real-time drug screening via in situ sequencing.

ER-targeting pro-fluorophore sensors detect endogenous peroxynitrite without cytokine stimulation, resolving sensitivity and physiological relevance trade-offs.

Stimulating afferent vagal nerves activates efferent sympathetic pathways to regulate adipose tissue metabolism, bypassing unclear hepatic PPARγ2 mechanisms.

Peptide complexes bind Tissue Factor Pathway Inhibitor epitopes to enhance thrombin generation.

Engineered TNFR-1B mutants enable precise screening of candidate therapeutic compounds.

Fluorescent alginate capsules enable simultaneous multi-cell type analysis, resolving screening time versus evaluation comprehensiveness trade-offs.

Puromycin analogs covalently label nascent polypeptides, bypassing methionine analog constraints to enable whole animal protein synthesis imaging.

Isolating novel antigen binding domains from immune cells to create validated CAR libraries for therapeutic targeting.

Selective TNFR1 and TNFR2 modulators target specific cellular pathways to promote tissue repair or inhibit proliferation.

Differentiating primate pluripotent stem cells into functional basal forebrain cholinergic and GABA neurons using specific signaling molecule concentrations.

Ratiometric coumarin tracers measure antioxidant activity in living stem cells, enabling efficient screening of high-quality therapeutic candidates.

A CD300c inhibitor composition activates tumor-infiltrating lymphocytes and cytotoxic T cells to suppress cancer cell proliferation.